
Jairaj Manohar Purandare
About Jairaj Manohar Purandare
Data last updated:
Jairaj Manohar Purandare is a Director at Piramal Pharma Limited (since 2021), Director at Cie Automotive India Limited (since 2023) and Director at Payu Payments Private Limited (since 2024), and holds 4 more current directorships. The companies operate in Pharma, Automotive and Financial Services. The 6 current companies with reported revenue have a combined latest revenue of ₹30,241 Cr; the largest is Piramal Pharma Limited at ₹9,082 Cr (FY 2026). Earlier, Jairaj Manohar Purandare was a Director at Pricewaterhousecoopers Private Limited (2004–2011) and Director at Young Presidents Organization (Mumbai Chapter) (2006–2008) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Feb 2021 | 2020 | ₹9,082 Cr (FY 2026) | Active | |
| Director | 10 Jun 2023 | 1999 | ₹8,811 Cr (FY 2023) | Active | |
| Director | 01 Feb 2024 | 2006 | ₹5,597 Cr (FY 2025) | Active | |
| Director | 28 Apr 2022 | 1998 | ₹3,582 Cr (FY 2026) | Active | |
| Director | 31 Oct 2018 | 1999 | ₹3,163 Cr (FY 2024) | Active | |
| Director | 18 Dec 2012 | 2012 | ₹5.08 Cr (FY 2025) | Active | |
| Designated Partner | 06 May 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Dec 2004 | 1983 | ₹3,862 Cr (FY 2024) | Active | |
| Director | 01 Jul 2006 | 1997 | ₹13.68 Cr (FY 2025) | Active | |
| Director | 17 Sep 2013 | 1996 | ₹20.9 Lakh (FY 2023) | Amalgamated | |
| Director | 19 Feb 2015 | 1955 | ₹2,147 Cr (FY 2025) | Active | |
| Director | 16 Sep 2011 | 1943 | ₹15,454 Cr (FY 2024) | Active | |
| Director | 29 Sep 2014 | 1968 | ₹3.78 Cr (FY 2022) | Active | |
| Director | 31 Aug 2012 | 2012 | Strike Off | ||
| Designated Partner | 21 Sep 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jairaj Manohar Purandare
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jairaj Manohar Purandare
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jairaj Manohar Purandare
Jairaj Manohar Purandare currently holds 7 directorships: Piramal Pharma Limited (Director, since 09 Feb 2021, revenue ₹9,082 Cr (FY 2026)); Cie Automotive India Limited (Director, since 10 Jun 2023, revenue ₹8,811 Cr (FY 2023)); Payu Payments Private Limited (Director, since 01 Feb 2024, revenue ₹5,597 Cr (FY 2025)); Indegene Limited (Director, since 28 Apr 2022, revenue ₹3,582 Cr (FY 2026)); Hdfc Asset Management Company Limited (Director, since 31 Oct 2018, revenue ₹3,163 Cr (FY 2024)); and 2 more.
Jairaj Manohar Purandare was first appointed on 15 Dec 2004 as Director at Pricewaterhousecoopers Private Limited. The most recent appointment on record is 01 Feb 2024 at Payu Payments Private Limited.
The 6 current companies of Jairaj Manohar Purandare that report revenue have a combined latest revenue of ₹30,241 Cr: Piramal Pharma Limited ₹9,082 Cr (FY 2026); Cie Automotive India Limited ₹8,811 Cr (FY 2023); Payu Payments Private Limited ₹5,597 Cr (FY 2025); Indegene Limited ₹3,582 Cr (FY 2026); Hdfc Asset Management Company Limited ₹3,163 Cr (FY 2024); and 1 more.
Jairaj Manohar Purandare held 8 earlier board appointments: Pricewaterhousecoopers Private Limited (Director, 15 Dec 2004 to 31 Aug 2011); Young Presidents Organization (Mumbai Chapter) (Director, 01 Jul 2006 to 01 Jul 2008); L&T Mutual Fund Trustee Limited (Director, 17 Sep 2013 to 08 Aug 2017); S H Kelkar And Company Limited (Director, 19 Feb 2015 to 19 Feb 2022); Rbl Bank Limited (Director, 16 Sep 2011 to 16 Sep 2019); and 3 more.
The current boards of Jairaj Manohar Purandare's companies include Amit Jain (Piramal Pharma Limited), Nandini Ajay Piramal (Piramal Pharma Limited), Nathalie Ann Leitch (Piramal Pharma Limited), Peter Andrew Stevenson (Piramal Pharma Limited), Peter D Deyoung (Piramal Pharma Limited), Ramadorai Subramanian (Piramal Pharma Limited), among others.